Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2016

01.08.2016 | Review Article

Chronic Pruritus in the Absence of Skin Disease: Pathophysiology, Diagnosis and Treatment

verfasst von: Manuel P. Pereira, Andreas E. Kremer, Thomas Mettang, Sonja Ständer

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Chronic pruritus arises not only from dermatoses, but also, in up to half of cases, from extracutaneous origins. A multitude of systemic, neurological, psychiatric, and somatoform conditions are associated with pruritus in the absence of skin disease. Moreover, pruritus is a frequently observed side effect of many drugs. It is therefore difficult for physicians to make a correct diagnosis. Chronic pruritus patients frequently present to the dermatologist with skin lesions secondary to a long-lasting scratching behavior, such as lichenification and prurigo nodularis. A structured clinical history and physical examination are essential in order to evaluate the pruritus, along with systematic, medical history-adapted laboratory and radiological tests carried out according to the differential diagnosis. For therapeutic reasons, a symptomatic therapy should be promptly initiated parallel to the diagnostic procedures. Once the underlying factor(s) leading to the pruritus are identified, a targeted therapy should be implemented. Importantly, the treatment of accompanying disorders such as sleep disturbances or mental symptoms should be taken into consideration. Even after successful treatment of the underlying cause, pruritus may persist, likely due to chronicity processes including peripheral and central sensitization or impaired inhibition at spinal level. A vast arsenal of topical and systemic agents targeting these pathophysiological mechanisms has been used to deter further chronicity. The therapeutic options currently available are, however, still insufficient for many patients. Thus, future studies aiming to unveil the complex mechanisms underlying chronic pruritus and develop new therapeutic agents are urgently needed.
Literatur
1.
Zurück zum Zitat Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87(4):291–4.PubMedCrossRef Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87(4):291–4.PubMedCrossRef
2.
Zurück zum Zitat Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7):535–47.PubMedCrossRef Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7(7):535–47.PubMedCrossRef
3.
Zurück zum Zitat Stander S, Pogatzki-Zahn E, Stumpf A, Fritz F, Pfleiderer B, Ritzkat A, Bruland P, Lotts T, Muller-Tidow C, Heuft G, Pavenstadt HJ, Schneider G, Van Aken H, Heindel W, Wiendl H, Dugas M, Luger TA. Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol. 2015;95(3):266–71.PubMedCrossRef Stander S, Pogatzki-Zahn E, Stumpf A, Fritz F, Pfleiderer B, Ritzkat A, Bruland P, Lotts T, Muller-Tidow C, Heuft G, Pavenstadt HJ, Schneider G, Van Aken H, Heindel W, Wiendl H, Dugas M, Luger TA. Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol. 2015;95(3):266–71.PubMedCrossRef
4.
Zurück zum Zitat Leader B, Carr CW, Chen SC. Pruritus epidemiology and quality of life. Handb Exp Pharmacol. 2015;226:15–38.PubMedCrossRef Leader B, Carr CW, Chen SC. Pruritus epidemiology and quality of life. Handb Exp Pharmacol. 2015;226:15–38.PubMedCrossRef
6.
Zurück zum Zitat Liu T, Ji RR. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch. 2013;465(12):1671–85.PubMedCrossRef Liu T, Ji RR. New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch. 2013;465(12):1671–85.PubMedCrossRef
7.
Zurück zum Zitat Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH, Ringkamp M. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci. 2007;27(28):7490–7.PubMedCrossRef Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH, Ringkamp M. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci. 2007;27(28):7490–7.PubMedCrossRef
8.
Zurück zum Zitat Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjork HE, Handwerker HO. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol. 2003;89(5):2441–8.PubMedCrossRef Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjork HE, Handwerker HO. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol. 2003;89(5):2441–8.PubMedCrossRef
9.
Zurück zum Zitat Johanek LM, Meyer RA, Friedman RM, Greenquist KW, Shim B, Borzan J, Hartke T, LaMotte RH, Ringkamp M. A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci. 2008;28(30):7659–69.PubMedPubMedCentralCrossRef Johanek LM, Meyer RA, Friedman RM, Greenquist KW, Shim B, Borzan J, Hartke T, LaMotte RH, Ringkamp M. A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci. 2008;28(30):7659–69.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol. 2008;17(3):161–9.PubMedCrossRef Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol. 2008;17(3):161–9.PubMedCrossRef
11.
Zurück zum Zitat van Laarhoven AI, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PC, Evers AW. Heterotopic pruritic conditioning and itch–analogous to DNIC in pain? Pain. 2010;149(2):332–7.PubMedCrossRef van Laarhoven AI, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PC, Evers AW. Heterotopic pruritic conditioning and itch–analogous to DNIC in pain? Pain. 2010;149(2):332–7.PubMedCrossRef
12.
Zurück zum Zitat Misery L, Brenaut E, Le Garrec R, Abasq C, Genestet S, Marcorelles P, Zagnoli F. Neuropathic pruritus. Nat Rev Neurol. 2014;10(7):408–16.PubMedCrossRef Misery L, Brenaut E, Le Garrec R, Abasq C, Genestet S, Marcorelles P, Zagnoli F. Neuropathic pruritus. Nat Rev Neurol. 2014;10(7):408–16.PubMedCrossRef
13.
14.
Zurück zum Zitat Misery L. Frontiers in neuroscience, pruritus in cutaneous T-cell lymphomas. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton: CRC Press/Taylor & Francis Group, LLC.; 2014. Misery L. Frontiers in neuroscience, pruritus in cutaneous T-cell lymphomas. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton: CRC Press/Taylor & Francis Group, LLC.; 2014.
15.
Zurück zum Zitat Krajnik M, Zylicz Z. Pruritus in advanced internal diseases. Pathogenesis and treatment. Neth J Med. 2001;58(1):27–40.PubMedCrossRef Krajnik M, Zylicz Z. Pruritus in advanced internal diseases. Pathogenesis and treatment. Neth J Med. 2001;58(1):27–40.PubMedCrossRef
16.
Zurück zum Zitat Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol. 2015;90(2):162–73.PubMedCrossRef Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol. 2015;90(2):162–73.PubMedCrossRef
17.
Zurück zum Zitat Abdel-Naser MB, Zaki MS, Mousa MH, Hamed H, Rizk MS, Mohamed HE, Habib MA. Cutaneous mononuclear cells and eosinophils are significantly increased after warm water challenge in pruritic areas of polycythemia vera. J Cutan Pathol. 2007;34(12):924–9.PubMedCrossRef Abdel-Naser MB, Zaki MS, Mousa MH, Hamed H, Rizk MS, Mohamed HE, Habib MA. Cutaneous mononuclear cells and eosinophils are significantly increased after warm water challenge in pruritic areas of polycythemia vera. J Cutan Pathol. 2007;34(12):924–9.PubMedCrossRef
18.
Zurück zum Zitat Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.PubMedCrossRef Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.PubMedCrossRef
19.
Zurück zum Zitat Weiss M, Mettang T, Tschulena U, Passlick-Deetjen J, Weisshaar E. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol. 2015;95(7):816–21.PubMed Weiss M, Mettang T, Tschulena U, Passlick-Deetjen J, Weisshaar E. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol. 2015;95(7):816–21.PubMed
21.
Zurück zum Zitat Papoiu AD, Emerson NM, Patel TS, Kraft RA, Valdes-Rodriguez R, Nattkemper LA, Coghill RC, Yosipovitch G. Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. J Neurophysiol. 2014;112(7):1729–38.PubMedPubMedCentralCrossRef Papoiu AD, Emerson NM, Patel TS, Kraft RA, Valdes-Rodriguez R, Nattkemper LA, Coghill RC, Yosipovitch G. Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. J Neurophysiol. 2014;112(7):1729–38.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J. 1021;2010(86):641–7. Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J. 1021;2010(86):641–7.
23.
Zurück zum Zitat Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60(1):399–407.PubMedCrossRef Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60(1):399–407.PubMedCrossRef
24.
Zurück zum Zitat Stander S, Zeidler C, Magnolo N, Raap U, Mettang T, Kremer AE, Weisshaar E, Augustin M. Clinical management of pruritus. J Dtsch Dermatol Ges. 2015;13(2):101–15.PubMed Stander S, Zeidler C, Magnolo N, Raap U, Mettang T, Kremer AE, Weisshaar E, Augustin M. Clinical management of pruritus. J Dtsch Dermatol Ges. 2015;13(2):101–15.PubMed
25.
Zurück zum Zitat Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.PubMedPubMedCentralCrossRef Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Reich A, Stander S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89(3):236–44.PubMedCrossRef Reich A, Stander S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89(3):236–44.PubMedCrossRef
28.
Zurück zum Zitat Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):1625–34.PubMedCrossRef Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):1625–34.PubMedCrossRef
29.
Zurück zum Zitat Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z. Itch: scratching more than the surface. QJM. 2003;96(1):7–26.PubMedCrossRef Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z. Itch: scratching more than the surface. QJM. 2003;96(1):7–26.PubMedCrossRef
30.
Zurück zum Zitat Stander S, Schmelz M. Chronic itch and pain–similarities and differences. Eur J Pain. 2006;10(5):473–8.PubMedCrossRef Stander S, Schmelz M. Chronic itch and pain–similarities and differences. Eur J Pain. 2006;10(5):473–8.PubMedCrossRef
31.
Zurück zum Zitat Brenaut E, Marcorelles P, Genestet S, Menard D, Misery L. Pruritus: an underrecognized symptom of small-fiber neuropathies. J Am Acad Dermatol. 2015;72(2):328–32.PubMedCrossRef Brenaut E, Marcorelles P, Genestet S, Menard D, Misery L. Pruritus: an underrecognized symptom of small-fiber neuropathies. J Am Acad Dermatol. 2015;72(2):328–32.PubMedCrossRef
32.
Zurück zum Zitat Braud A, Toure B, Agbo-Godeau S, Descroix V, Boucher Y. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain. 2013;27(3):235–42.PubMed Braud A, Toure B, Agbo-Godeau S, Descroix V, Boucher Y. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain. 2013;27(3):235–42.PubMed
33.
Zurück zum Zitat Stumpf A, Stander S. Neuropathic itch: diagnosis and management. Dermatol Ther. 2013;26(2):104–9.PubMedCrossRef Stumpf A, Stander S. Neuropathic itch: diagnosis and management. Dermatol Ther. 2013;26(2):104–9.PubMedCrossRef
34.
Zurück zum Zitat Huesmann T, Cunha PR, Osada N, Huesmann M, Zanelato TP, Phan NQ, Gontijo GM, Marziniak M, Stander S. Notalgia paraesthetica: a descriptive two-cohort study of 65 patients from Brazil and Germany. Acta Derm Venereol. 2012;92(5):535–40.PubMedCrossRef Huesmann T, Cunha PR, Osada N, Huesmann M, Zanelato TP, Phan NQ, Gontijo GM, Marziniak M, Stander S. Notalgia paraesthetica: a descriptive two-cohort study of 65 patients from Brazil and Germany. Acta Derm Venereol. 2012;92(5):535–40.PubMedCrossRef
35.
Zurück zum Zitat Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry. 2008;30(4):344–8.PubMedCrossRef Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry. 2008;30(4):344–8.PubMedCrossRef
36.
Zurück zum Zitat Caccavale S, Bove D, Bove RM, La Montagna M. Skin and brain: itch and psychiatric disorders. G Ital Dermatol Venereol. 2015 [Epub ahead of print, PMID: 25854671]. Caccavale S, Bove D, Bove RM, La Montagna M. Skin and brain: itch and psychiatric disorders. G Ital Dermatol Venereol. 2015 [Epub ahead of print, PMID: 25854671].
37.
Zurück zum Zitat Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, Berger TG, Koo JY, Murase JE. Delusional infestations: clinical presentation, diagnosis and treatment. Int J Dermatol. 2013;52(7):775–83.PubMedCrossRef Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, Berger TG, Koo JY, Murase JE. Delusional infestations: clinical presentation, diagnosis and treatment. Int J Dermatol. 2013;52(7):775–83.PubMedCrossRef
38.
Zurück zum Zitat Elmariah SB. Careful considerations concerning psychogenic itch. JAMA Intern Med. 2015;175(11):1861.PubMedCrossRef Elmariah SB. Careful considerations concerning psychogenic itch. JAMA Intern Med. 2015;175(11):1861.PubMedCrossRef
39.
Zurück zum Zitat Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, Misery L, Szabo C, Linder D, Sampogna F, Evers AW, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984–91.PubMedPubMedCentralCrossRef Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, Misery L, Szabo C, Linder D, Sampogna F, Evers AW, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984–91.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat van Os-Medendorp H, Ros WJ, Eland-de Kok PC, Kennedy C, Thio BH, van der Schuur-van der Zande A, Grypdonck MH, Bruijnzeel-Koomen CA. Effectiveness of the nursing programme ‘Coping with itch’: a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol. 2007;156(6):1235–44. van Os-Medendorp H, Ros WJ, Eland-de Kok PC, Kennedy C, Thio BH, van der Schuur-van der Zande A, Grypdonck MH, Bruijnzeel-Koomen CA. Effectiveness of the nursing programme ‘Coping with itch’: a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol. 2007;156(6):1235–44.
41.
Zurück zum Zitat Johannesdottir SA, Farkas DK, Vinding GR, Pedersen L, Lamberg A, Sorensen HT, Olesen AB. Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol. 2014;171(4):839–46.PubMedCrossRef Johannesdottir SA, Farkas DK, Vinding GR, Pedersen L, Lamberg A, Sorensen HT, Olesen AB. Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol. 2014;171(4):839–46.PubMedCrossRef
42.
Zurück zum Zitat Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, Gieler U, Lotti T, Lambert J, Maisel P, Streit M, Greaves MW, Carmichael AJ, Tschachler E, Ring J, Stander S. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92(5):563–81.PubMedCrossRef Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, Gieler U, Lotti T, Lambert J, Maisel P, Streit M, Greaves MW, Carmichael AJ, Tschachler E, Ring J, Stander S. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92(5):563–81.PubMedCrossRef
43.
Zurück zum Zitat Siepmann D, Weishaupt C, Luger TA, Stander S. Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients. Dermatology. 2011;223(4):374–80.PubMedCrossRef Siepmann D, Weishaupt C, Luger TA, Stander S. Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients. Dermatology. 2011;223(4):374–80.PubMedCrossRef
44.
Zurück zum Zitat Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage. 2004;28(4):396–411.PubMedCrossRef Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage. 2004;28(4):396–411.PubMedCrossRef
46.
Zurück zum Zitat Kanitakis J. Brachioradial pruritus: report of a new case responding to gabapentin. Eur J Dermatol. 2006;16(3):311–2.PubMed Kanitakis J. Brachioradial pruritus: report of a new case responding to gabapentin. Eur J Dermatol. 2006;16(3):311–2.PubMed
47.
Zurück zum Zitat Yesudian PD, Wilson NJ. Efficacy of gabapentin in the management of pruritus of unknown origin. Arch Dermatol. 2005;141(12):1507–9.PubMedCrossRef Yesudian PD, Wilson NJ. Efficacy of gabapentin in the management of pruritus of unknown origin. Arch Dermatol. 2005;141(12):1507–9.PubMedCrossRef
48.
Zurück zum Zitat Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19(12):3137–9.PubMedCrossRef Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19(12):3137–9.PubMedCrossRef
49.
Zurück zum Zitat Ehrchen J, Stander S. Pregabalin in the treatment of chronic pruritus. J Am Acad Dermatol. 2008;58(2 Suppl):S36–7.PubMedCrossRef Ehrchen J, Stander S. Pregabalin in the treatment of chronic pruritus. J Am Acad Dermatol. 2008;58(2 Suppl):S36–7.PubMedCrossRef
50.
Zurück zum Zitat Porzio G, Aielli F, Verna L, Porto C, Tudini M, Cannita K, Ficorella C. Efficacy of pregabalin in the management of cetuximab-related itch. J Pain Symptom Manage. 2006;32(5):397–8.PubMedCrossRef Porzio G, Aielli F, Verna L, Porto C, Tudini M, Cannita K, Ficorella C. Efficacy of pregabalin in the management of cetuximab-related itch. J Pain Symptom Manage. 2006;32(5):397–8.PubMedCrossRef
51.
Zurück zum Zitat Kremer AE, Namer B, Bolier R, Fischer MJ, Oude Elferink RP, Beuers U. Pathogenesis and management of pruritus in PBC and PSC. Dig Dis. 2015;33(Suppl 2):164–75.PubMedCrossRef Kremer AE, Namer B, Bolier R, Fischer MJ, Oude Elferink RP, Beuers U. Pathogenesis and management of pruritus in PBC and PSC. Dig Dis. 2015;33(Suppl 2):164–75.PubMedCrossRef
52.
Zurück zum Zitat Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11(3):514–9.PubMed Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11(3):514–9.PubMed
53.
Zurück zum Zitat Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, laina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 1996;348(9041):1552–4. Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, laina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 1996;348(9041):1552–4.
54.
Zurück zum Zitat Phan NQ, Bernhard JD, Luger TA, Stander S. Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010;63(4):680–8.PubMedCrossRef Phan NQ, Bernhard JD, Luger TA, Stander S. Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010;63(4):680–8.PubMedCrossRef
55.
Zurück zum Zitat Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manag. 2003;25(3):288–91.CrossRef Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manag. 2003;25(3):288–91.CrossRef
56.
Zurück zum Zitat Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002;99(7):2627.PubMedCrossRef Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002;99(7):2627.PubMedCrossRef
57.
Zurück zum Zitat Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manag. 1998;16(2):121–4.CrossRef Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manag. 1998;16(2):121–4.CrossRef
58.
Zurück zum Zitat Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom. 2000;69(3):165–6.PubMedCrossRef Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom. 2000;69(3):165–6.PubMedCrossRef
59.
Zurück zum Zitat Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manag. 2003;26(6):1105–12.CrossRef Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manag. 2003;26(6):1105–12.CrossRef
60.
Zurück zum Zitat Stander S, Bockenholt B, Schurmeyer-Horst F, Weishaupt C, Heuft G, Luger TA, Schneider G. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol. 2009;89(1):45–51.PubMedCrossRef Stander S, Bockenholt B, Schurmeyer-Horst F, Weishaupt C, Heuft G, Luger TA, Schneider G. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol. 2009;89(1):45–51.PubMedCrossRef
61.
Zurück zum Zitat Stander S, Weisshaar E, Raap U. Emerging drugs for the treatment of pruritus. Expert Opin Emerg Drugs. 2015;20(3):515–21.PubMedCrossRef Stander S, Weisshaar E, Raap U. Emerging drugs for the treatment of pruritus. Expert Opin Emerg Drugs. 2015;20(3):515–21.PubMedCrossRef
62.
Zurück zum Zitat Stander S, Siepmann D, Herrgott I, Sunderkotter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One. 2010;5(6):e10968.PubMedPubMedCentralCrossRef Stander S, Siepmann D, Herrgott I, Sunderkotter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One. 2010;5(6):e10968.PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med. 2009;361(14):1415–6.PubMedCrossRef Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med. 2009;361(14):1415–6.PubMedCrossRef
64.
Zurück zum Zitat Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, Yamashita N. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol. 2014;171(22):5049–58.PubMedPubMedCentral Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, Yamashita N. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol. 2014;171(22):5049–58.PubMedPubMedCentral
65.
Zurück zum Zitat Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci. 2005;99(3):277–86.PubMedCrossRef Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci. 2005;99(3):277–86.PubMedCrossRef
66.
Zurück zum Zitat Phan NQ, Lotts T, Antal A, Bernhard JD, Stander S. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venereol. 2012;92(5):555–60.PubMedCrossRef Phan NQ, Lotts T, Antal A, Bernhard JD, Stander S. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venereol. 2012;92(5):555–60.PubMedCrossRef
68.
Zurück zum Zitat Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16(12):3742–7.PubMedCrossRef Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16(12):3742–7.PubMedCrossRef
69.
Zurück zum Zitat Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, Scheewe S, Scheidt R, Schmid-Ott G, Schnopp C, Szczepanski R, Werfel T, Wittenmeier M, Wahn U, Gieler U. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332(7547):933–8.PubMedPubMedCentralCrossRef Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, Scheewe S, Scheidt R, Schmid-Ott G, Schnopp C, Szczepanski R, Werfel T, Wittenmeier M, Wahn U, Gieler U. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332(7547):933–8.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Evers AW, Duller P, de Jong EM, Otero ME, Verhaak CM, van der Valk PG, van de Kerkhof PC, Kraaimaat FW. Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. Acta Derm Venereol. 2009;89(1):57–63.PubMedCrossRef Evers AW, Duller P, de Jong EM, Otero ME, Verhaak CM, van der Valk PG, van de Kerkhof PC, Kraaimaat FW. Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. Acta Derm Venereol. 2009;89(1):57–63.PubMedCrossRef
71.
Zurück zum Zitat Bathe A, Matterne U, Dewald M, Grande T, Weisshaar E. Educational multidisciplinary training programme for patients with chronic pruritus. Acta Derm Venereol. 2009;89(5):498–501.PubMedCrossRef Bathe A, Matterne U, Dewald M, Grande T, Weisshaar E. Educational multidisciplinary training programme for patients with chronic pruritus. Acta Derm Venereol. 2009;89(5):498–501.PubMedCrossRef
Metadaten
Titel
Chronic Pruritus in the Absence of Skin Disease: Pathophysiology, Diagnosis and Treatment
verfasst von
Manuel P. Pereira
Andreas E. Kremer
Thomas Mettang
Sonja Ständer
Publikationsdatum
01.08.2016
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2016
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0198-0

Weitere Artikel der Ausgabe 4/2016

American Journal of Clinical Dermatology 4/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.